AwardTape · Defense awards · Medical · Health care services · W81K0025CA004
W81K0025CA004: $246K definitive contract to Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation holds a definitive contract from Department of the Army with $246K obligated since Oct 2023, against a ceiling of $681K. Latest action Feb 18, 2026.
Clonoseq fda-cleared in vitro diagnostic (ivd) testing services
| PIID | W81K0025CA004 |
|---|---|
| Type | definitive contract |
| Company | Adaptive Biotechnologies Corporation |
| Agency | Department of the Army |
| Contracting office | W40M MRC0 WEST |
| Category | Medical · Health care services |
| PSC | Q301 REFERENCE LABORATORY TESTING |
| NAICS | 621511 MEDICAL LABORATORIES |
| Obligated since Oct 2023 | $246K |
| Total obligated (lifetime) | $246K |
| Ceiling (base and all options) | $681K |
| Base date | Mar 14, 2025 |
| Latest action | Feb 18, 2026 |
| End date | Mar 13, 2030 |
| Actions since Oct 2023 | 5 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | TX |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial